1+ day, 10+ hour ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

3+ day, 10+ hour ago   (1556+ words) How agentic artificial intelligence is transforming the value chain from discovery to commercialization. The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human guidance, agentic…...

4+ day, 22+ hour ago   (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...

2+ week, 4+ day ago   (57+ words) Why Global Science Innovation is Shifting to Asia Pharmaceutical Executive Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA What Executives and Investors Are Looking for in Pharma Companies FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and…...

2+ week, 4+ day ago   (118+ words) Pharmaceutical Executive Why traditional power calculations leave asset value on the table, and how adaptive frameworks change the math on risk. Most Phase 2 trials are sized on a guess seen as mathematics. You are in the trial design meeting, your…...

2+ week, 6+ day ago   (219+ words) You've seen it before: an AI pilot that works in testing, then stalls the moment someone asks you to reproduce the result. The cause usually isn't the model—it's what wasn't built around it. Komodo Health built this framework from…...

3+ week, 3+ day ago   (209+ words) Pharmaceutical Executive Earlier this year, Pharmaceutical Executive reported on China’s growing prominence in the pharma and biotech spaces During this year, billions of dollars have been committed to licensing commitments with Chinese companies, with many US-based companies making up…...

3+ week, 2+ day ago   (340+ words) Amplitude Therapeutics enters a collaboration with Eli Lilly to develop trans-amplifying RNA vaccines, while Chai Discovery partners with Bristol Myers Squibb to deploy its AI molecular folding and design models across BMS's antibody discovery portfolio. As of August 21, financial terms…...

3+ week, 4+ day ago   (53+ words) Pharmaceutical Executive From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle Most pharma companies have promising AI pilots. Few have built the conditions to scale them. Here's what separates the leaders from the rest....